Business Wire

Delcath Systems, Inc. Announces Inclusion of CHEMOSAT Hepatic Delivery System for Melphalan as a Recommended Liver-Directed Regional Therapy Option in the ESMO–EURACAN ...

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on liver-directed cancer therapies, today announced that its proprietary CHEMOSAT ® ...
Morningstar

Delcath Systems Announces Publication of Subgroup Analyses of the Phase 3 FOCUS Study of Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma

Delcath Systems Announces Publication of Subgroup Analyses of the Phase 3 FOCUS Study of Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma Delcath Systems, Inc.
Monthly Prescribing Reference

Melphalan/Hepatic Delivery System Beneficial for Metastatic Uveal Melanoma

Serious adverse events occurred in 51.2 and 21.9% of patients receiving melphalan/hepatic delivery system and BAC, respectively. HealthDay News — For patients with unresectable metastatic uveal ...
The New England Journal of Medicine

The Clinical Significance of Some Peculiarities of the Circulation in the Kidneys, Liver, Lungs and Heart

REFLECTION on the functional significance of the valves in the veins and in the heart led Colombo and Cesalpino to postulate a circulatory system in place of the long-accepted tidal flow of blood from ...
News Medical

From Dose to Circulation: Determination of Drug Oral Bioavailability Using a Gut-Liver Microphysiological System

Learn how bioavailability can be determined in vitro using human cells Discover how gut-liver MPS can be used to evaluate a key ADME parameter Discuss the application of mathematical modeling to ...
National Institute for Health and Care Excellence

Melphalan chemosaturation with percutaneous hepatic artery perfusion and hepatic vein isolation for primary or metastatic cancer in the liver

The most common types of primary liver cancer are hepatocellular carcinoma (also known as hepatoma) and cholangiocarcinoma. However, cancer in the liver has often metastasised from other sites such as ...
News Medical

Machine learning model boosts success of liver transplants from circulatory death donors

While most liver donations come from donors who suffered brain death, the number of donations after circulatory death is growing. "The number of liver transplants keeps going up because of donation ...